• Protein Tomography ? to Improve Success in Drug Development

Laboratory products

Protein Tomography ? to Improve Success in Drug Development

FEI Company and Sweden-based Sidec Technologies AB are collaborating on the commercialization of Protein Tomography? solutions and services based on Sidec's proprietary software and intellectual property, and FEI's transmission electron microscopes (TEMs).

Protein Tomography is a new technology developed to address critical issues around drug target validation and translational medicine in the pharmaceutical industry, improving target validation processes and shortening development time for new pharmaceuticals.

FEI has led the development of cryo electron microscopy for the imaging of biological structures in close collaboration with many top level academic groups in Europe and the US. Sidec is pioneering the field of protein imaging using cryo electron tomography and has several research collaborations with global pharmaceutical companies.

Protein Tomography consists of advanced electron microscopy instrumentation, proprietary data acquisition and reconstruction software as well as scientific expertise to enable the imaging and analysis of individual protein molecules in cells and tissues. FEI and Sidec offer this as a service through Sidec, as an on-premises service, or through a software and other intellectual property license arrangement combined with a TEM system sale.

Digital Edition

ILM 50.3 April 2025

May 2025

Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...

View all digital editions

Events

Future Labs Live Basel 2025

May 27 2025 Basel, Switzerland

ASMS Conference

Jun 01 2025 Baltimore, MD, USA

Chemspec Europe 2025

Jun 04 2025 Koeln, Germany

Lab & Test Asia

Jun 11 2025 Bangkok, Thailand

HPLC 2025

Jun 15 2025 Bruges, Belgium

View all events